Schizophrenia & Other Psychotic Disorders
Conference Coverage
Quick medication, better communication linked to less violence at inpatient psych unit
Clinicians emphasized quick access to antipsychotic medication and more staff communication.
Conference Coverage
Black patients most likely to be restrained in EDs, Latino patients least likely
Researchers blame racism for both findings of an analysis of three North Carolina hospitals.
Commentary
Choosing our terms: The diagnostic words we use can be harmful
Can psychiatry find better terms to communicate hard to hear information, with words that are less problematic?
From the Journals
Young men at highest schizophrenia risk from cannabis abuse
For young men aged 21-30, the proportion of preventable schizophrenia cases related to cannabis abuse disorder may be as high as 30%.
From the Journals
Widespread prescribing of stimulants with other CNS-active meds
CNS-active drug classes included antidepressants, anxiolytics/sedatives/hypnotics, antipsychotics, opioids, anticonvulsants, and other...
From the Journals
New tool accurately predicts suicide risk in serious mental illness
“It is also essential to remember that OxMIS is not intended to replace clinical decision-making, but rather to support it,” said Dr. Amir...
From the Journals
Erratic sleep, lack of activity tied to worsening schizophrenia symptoms
Compared with healthy control participants, patients with schizophrenia had more total sleep time and spent more time resting or being passive.
From the Journals
Clozapine may curb schizophrenia’s ‘most dreaded outcome’
Clozapine has a “greater antidepressant effect than other neuroleptics, while also potentially decreasing aggression and impulsivity.”
From the Journals
New schizophrenia genes identified
“There’s reason to believe if you can find a mechanism by which a human being could develop a psychosis, then reversing that mechanism could help...
Conference Coverage
Add-on antipsychotic beats switching meds in older adults with resistant depression
“These results are of great impact for clinicians managing older adults with treatment-resistant depression,” said Dr. Jennifer Gatchel.
Conference Coverage
Antipsychotic cuts Alzheimer’s-related agitation
Brexpiprazole will become the first drug to be approved for agitation in AD, doctor speculates.